chrisvoncsefalvay/vaers-outcomes huggingface dataset:
laryngitis; cough; sore throat lower throat; swollen lymph nodes in neck both sides; swollen tonsil left side; severe tonsil pain; difficulty swallowing; Sore arm muscle; tiredness; feeling unwell; low mood; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (Patient).   A 52-years-old female patient (Non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in arm Left on 19Jul2021 at 14:30 pm (at the age of 52-years-old, Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. Medical history included menopausal, cervical stenosis spinal cord, pineal gland cyst, degenerative disc disease, past uterine fibroids, hypothyroidism, ovarian cysts all were from an unknown date and unknown if ongoing. Concomitant medication(s) included paracetamol (TYLENOL), melatonin and multivitamin all were taken for an unspecified indication, start and stop date were not reported. The patient previously took Levaquin and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was reported as pharmacy or drug Store. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 19Jul2021 at 14:30 pm the patient received the first dose of vaccine and on day 2-3 on 20Jul2021 at 04:00 she experienced sore arm muscle, tiredness, feeling unwell, low mood, diarrhea. On day 4-8 on 22Jul2021 she had swollen lymph nodes in neck both sides, swollen tonsil left side, severe tonsil pain, difficulty swallowing. On day 9-14 on 27Jul2021 experienced sore throat lower throat, laryngitis and cough. Patient did not received any treatment to treat the events and was not hospitalized. The patient was recovered from the events of muscle pain, tiredness, feeling unwell, low mood, diarrhea on 21Jul2021, recovered from the events of swollen lymph nodes, swollen tonsils, tonsillitis and swallowing difficult on 26Jul2021 and from the events laryngitis, oropharyngeal pain and cough on 01Aug2021.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
My symptoms began on 04/18/2023 in the morning I had a really bad sore throat. It progressed to coughing mucus, and nasal drainage. I also had pink eyes. On 04/20/2023 I went to the pharmacy and got a COVID-19 test which was positive. I did a telehealth with my doctor on the same day. She prescribed me PAXLOVID for 5 days, and albuterol. I took over the counter cough syrup for cough. I contacted my eye doctor on the 04/25/2023. I was prescribed eye drop tobramycin for 3 weeks. As of now I have unproductive cough and other symptoms are gone.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: ER8730), in left arm, on 14Apr2021 as dose 2, single (Lot number: 9W0151), in right arm and on 19Nov2021 as dose 3 (booster), single (Lot number: 302308D) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "history of congestive heart failure" (unspecified if ongoing); "obesity" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION, start date: 01Jun1997; ASMANEX, start date: 01Mar2016; FLONASE [FLUTICASONE PROPIONATE], start date: 01Aug2016. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid from 28Oct2022 to 01Nov2022.
Patient had a large red knot on the injection site, complained had trouble putting weight on that side especially sitting or lying down for the next couple  days following the administration of the vaccine.
Headache Runny nose, redness and pain at the injection site, pain in the left groin area Narrative:
Guillain-Barre syndrome-- pt developed weakness, ataxia, and difficulty walking.  Was treated with IVIG x 5 days.  Clinically improved prior to d/c from hospital on 08/22/2012.  Now receiving PT services as outpatient.
Pt presented to ER with c/o abd pain and cramping in the left upper quadrant. Occurred 3 days ago. Pt received her 1st Pfizer vaccine 8 days ago at an out of state location. During ER visit, pt's HR was elevated and increased greatly with any exertion up to 135-150s. ER physician is concerned for possible myocarditis and discharged the patient with a referral for an echocardiogram and cardiology appt referral.
Pt exp a slight reaction following vax w/pneumococcal vax; No further details were provided;
patient received #1 moderna on 3/27/21, #2 on 5/2/21. After 1st moderna patient presented to the ER on 3/31/21 for evaluation of fatigue, headache, tingling to left thigh. COVID-19 testing negative at that time. Provider visit 4/2 for moderate -severe adverse reaction. Seen again on 4/19 and in discussion w/ provider decided to get 2nd dose. Per messages from patient, she experienced nausea, headache, myalgias, hot/cold sweats after second dose. now with persistent numb patch with allodynia over left thigh.   Recommended that SI be submitted for DH immunization group review to see if VAERS tracking submission needed.
No adverse event; Patient received expired Moderna Bivalent vaccine no other adverse events were reported.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine no other adverse events were reported.) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Jul-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine no other adverse events were reported.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine no other adverse events were reported.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine no other adverse events were reported.).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732810 (E2B Linked Report). This case was linked to MOD-2023-732790 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732810:same reporter
2 days after 2nd dose of Pfizer vaccine  she began experiencing a sensation of swelling in her neck, although it was not visibly evident or compromising her airway.   This seemed to resolve with taking Benadryl.  At that time she also began feeling thyroid pain which has persisted for >3 months and is still not resolved.
swelling, warm and red hive like eruption 2 1/2 cm at site of injection RVL
This spontaneous report has been received from a medical assistant referring to multiple patients of unknown age or gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with an improperly stored dose of ROTATEQ (strength and dose were not reported), lot # M019690 with expiration date on 02-NOV-2017 and lot # M038724 with expiration date on 24-APR-2018, orally for prophylaxis; which experienced a temperature excursion between 47 and 77 Fahrenheit degrees for 50 minutes. Previous temperature excursion was between 47 and 77 Fahrenheit degrees for 3 hours. Data logger was involved. No adverse effects were reported and no additional information was provided. A product quality complaint was not involved. This is one of multiple reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA001034: US-009507513-1706USA001035: US-009507513-1705USA008599.
Report received from a nurse on 20-OCT-2010 (via License partner: 1010USA02642). An approximately 30 year old female patient (date of birth: unknown) received AFLURIA on 11-SEP-2010 for indication 'to administer for flu vaccine'. Batch number and details are unknown. It is unknown if the patient had a medical history or was taking concomitant medications. On 11-SEP-2010, the same day as vaccination with AFLURIA, the patient experienced a rapid heart rate, 101 degree fever, sweating and was really sore. The patient sought attention however treatment was unspecified. The patient outcome was reported as recovered with date unspecified. The company considered events possible to the suspect drug, AFLURIA. Information derived from this AE report does not change the current safety profile of the product.
Within 48 hours the pt complained of crippling pain and swelling of the knees and ankles. The pt was unable to work at first. The pt was treated with Doxycycline, Celebrex and Ultram for 3 months.
pt recv vax & immed flet pain in shoulder, neck, head,arm, & in fingers;vax was discontinued;no tx was given;pain persisted 1 day later @ time of the report;
Breakthrough case admission after 3 vaccines  Pfizer 4/29/21 lot# Ew0167;  Pfizer 5/20/21 lot#Ew0183;  Pfizer 4/7/22 lot# FL3198
complaints: Lightheaded, weak  BP: 185/95 HR: 95 Sp02: 99% History of alcohol abuse. Reports she only ate breakfast today, and has been drinking alcohol all day with boyfriend.  Per sister and boyfriend, she was hospitalized last month for same symptom  due to alcohol abuse Seen and transported to ER by the EMS
Information has been received from a physician concerning a 20 year old female who on 26-JUL-2007 was vaccinated IM with the first dose of Gardasil (Lot#0530U).  Concomitant therapy included PULMICORT, CLARITIN, albuterol and ORTHO EVRA.  On 26-JUL-2007 post vaccination the patient fainted.  The physician reported that he found out after administering the vaccine that the patient had not eaten that morning.  Subsequently, before leaving the physician's office that day the patient had recovered from the event.  Additional information has been requested.  01/07/2008 This is in follow-up to report(s) previously submitted on 9/17/2007. Initial and follow up information has been received from a physician concerning a 20 year old female with asthma who on 26-JUL-2007 at 10:30 am was vaccinated IM with the first dose of GARDASIL (Lot#0530U). Concomitant therapy included PULMICORT, CLARITIN, albuterol and ORTHO EVRA. On 26-JUL-2007 post vaccination, while at the front desk the patient felt dizzy and fainted. Her vital signs were pulse 72 and BP 100/60 mmHG. Paramedics were called, however the patient refused to go the emergency room. The physician reported that he found out after administering the vaccine that the patient had not eaten that morning. Subsequently, before leaving the physician's office that day the patient had recovered from the event. The patient followed up with her primary care physician. Additional information has been requested.
Patient with known seizure disorder but has been seizure free for almost 18 months, had seizure on 2/22/21, 12 days after immunizations.  Parent now realized that he also had seizures following other vaccinations.  Had seizure within 2 weeks of varivax #1 in Feb 2019 and Pentacel #4 was given 4/5/19 and had seizure on 4/24/19.  Mom did not correlate seizures at the time in 2019 so was not mentioned then.   No seizures until 9/11/2018 and first 3 Pentacel vaccines were given 3/5/18, 5/8/18 and 8/6/18. Seizure on 2/22/21 was typical for him, needed diastat to stop seizure at 4.5 minutes.  No other intervention needed and patient has been back to his baseline since.
intermittent paresthesias and/or numbness of the extremities, varies in degree, location, and duration.  The entire hand, arm, foot or leg could have the sensation, just patches and pieces.  Initially started as a patch on the left arm but has progressed to the alternating areas and extent as mentioned above.  Occasionally into the trunk region and scalp.  Intermittent changes in vision/blurring of vision- so much that an eye doctor was seen.  New contacts were prescribed, but still having intermittent visual changes where focus is not accurate
He received a really intense rash that started within 3 days of the vaccines. They were very large , red and covered his entire body. This rash lasted for about 3 weeks. He still has a little rash on his right cheek and little bumps on both his arms but more bumps on the right arm   He just received his 15 month shots yesterday and the vaccine info was given to me by the nurse
10/20/07 c/o feeling bad, hot, headache, weak, dizzy, fever of 102 degrees, wheezing - 10/22/07 - Pt saw Dr. for viral infection-was given Rocephin shot - was given Cipro and Atuss 10/24/07-Pt not feeling better - returned to Dr. and was hospitalized for pneumonia improved but still having problems with wheezing.  12/20/2007 MR received for DOS 10/24-29/2007 with D/C DX:  Pneumonia.  Hypertension.  Diabetes Mellitus Type II. Chronic Kidney Disease.  hx of Breast CA with radiation.  Hypothyroidism.  Hyperlipidemia. Pt presented for direct admit from MD's office with c/o fever, cough, SOB and wheezing. Had previously txd with IM Rocephin and Cipro without resolution of sx. Pt txd with abx, steroids, nebs, and O2 prn.  Blood sugar elevations throughout admission.
I had a tight chest, coughing that was constant, shortness of breath I made an appointment with my doctor. I had a virtual appointment with my doctor. She ordered a chest x-ray and blood work to rule out pneumonia and infection. Everything came back normal. My doctor then prescribed Tessalon Perles for my cough, Flovent to help me breath for my asthma diagnosis and nasal spray to help keep my breathing passages open.
On Monday November 02, 2020, I went to the pharmacy to receive SHINGRIX vaccine. After receiving the SHINGRIX shot, I developed a burning and itching sensation accompanied by redness on the inside of the rectum and around the tailbone. The itching and burning was very annoying each and every day I applied different OTC medication to the affected area but the symptoms continued.    on Sunday November 15, 2020 I went to the clinic for medical attention.   I was diagnosed by the attending physician doctor, that I had shingles. Doctor prescribed the drug valacyclovir 1mg, to be take three times a day. I was prescribed a varitity of pills.       The symptoms continues, so I went to the dermatologist, in order to rid the hives and rashes on my buttocks and back.    Dermatologist prescribed the medications, Prednisone 10mg, Cephalexin 500mg and Triamcolone acetonide cream to be applied to the affected areas.  I finally got back to normaland have no annoying symptoms to deal with.
This medically confirmed report (initial receipt 06-Aug-2012) concerns a male patient, approximately 75 years old. On an unknown date, the patient received influenza vaccine (manufacturer and batch number not specified). An unknown time later, the patient developed Guillain Barre Syndrome. He was paralysed from the waist down. After a second dose of flu vaccine, the patient developed a milder case (refer to case 2012033058). The patient recovered after each case of GBS (Guillain Barre Syndrome). Reporter's comment: On 20-Aug-2012 the pharmacist commented that the patient's GBS following vaccination with an unspecified flu vaccine occurred approximately 7 years ago. She had no idea which flu vaccine the patient received approximately 7 years ago. Follow up (20-Aug-2012): reporter's comment.
17 hours after the vaccination I fainted/passed out.; 17 hours after the vaccination I fainted/passed out.; Interchange of vaccine product; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Nov2022 at 13:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ROSUVASTATIN. Vaccination history included: janssen (Dose 2,, lot number=213D21A,, location=Left arm), administration date: 03Jan2022, when the patient was 69-year-old, for COVID-19 immunization; janssen (Dose 1,, lot number=201A21A,, location=Left arm), administration date: 10Apr2021, when the patient was 69-year-old, for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 14Nov2022 at 13:30, outcome "unknown", described as "Interchange of vaccine product"; SYNCOPE (medically significant), LOSS OF CONSCIOUSNESS (medically significant) all with onset 15Nov2022 at 10:00, outcome "recovered" (2022) and all described as "17 hours after the vaccination I fainted/passed out.". The event "17 hours after the vaccination i fainted/passed out." required physician office visit. Therapeutic measures were not taken as a result of syncope, loss of consciousness.  Clinical Course: The patient had no medical history. No known allergies. Not covid tested post vaccination.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
became faint; racing heart; This spontaneous report was received from a consumer, referring to a 26-year-old female patient. Her medical history, concurrent conditions and concomitant medications were not reported.  On an unknown date in June 2022, the patient received first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (lot #, expiration date, dosage and exact anatomical location were not provided) for prophylaxis.  On an unknown date in June 2022, after receiving the vaccination, the patient became faint. Moreover, a week later, she had a racing heart and was taken to the emergency room. The outcome of the events was not reported.  The relatedness between the suspect vaccine and the events was not provided.  Upon internal review, the event of syncope was determined to be medically significant.
Arm became red/swollen/ hot to touch/ and painful 8 days after injection.
Headache, runny nose, sneezing, congestion, body aches, fatigue, coughing, loss of smell- lasted from 3/29/21 - 4/2/21 except for loss of smell. it still hasnt come back. Treatment: Musinex, theraflu, raw garlic, honey and vicks
muscle weakness; severe pain; flu symptoms; Initial information received on 18-Dec-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-health care professional.  This case involves a patient of unknown demographics who had flu symptoms, muscle weakness and severe pain after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 27-Sep-2022, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, expiry date, strength, formulation, route was unknown) in unknown administration site for prophylactic vaccination(Immunisation). Information regarding batch number details has been requested.  On 28-Sep-2022 the patient had a non-serious event of flu symptoms (influenza) (latency:1 day) following the administration of Influenza Vaccine.  On an unknown date the patient had non-serious events of muscle weakness (muscular weakness) and pain (unknown latency) following the administration of Influenza Vaccine.  It was reported "It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available."  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (flu symptoms, muscle weakness, severe pain).  At time of reporting, the outcome was Unknown for the event flu symptoms, was Unknown for the event muscle weakness and was Unknown for the event severe pain.
patient received an improperly stored dose of VARIVAX; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided.      On 03-SEP-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S019583, expiration date on 25-JUN-2021, for prophylaxis; reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT). Vaccine was improperly stored at a temperature of 21.9°F, during a time frame of 108 minutes, There was no previous temperature excursions and the call was not because of a data logger.
Case number PHEH2015US003143, is an initial spontaneous report received from a nurse on 10 Feb 2016. This report refers to an 11 years old patient whose gender was not reported. The patient's medical history and concomitant medications were not reported. On 14 Jan 2015, MENVEO (batch number: M14071, expiry date: Nov 2015) was at 0.4 degree Celsius for 1 hour and 16 minutes and the patient received 0.5 ml intramuscular dose of this frozen vaccine with excursion on 03 Feb 2015. The vaccine had two more other excursion as follows: on 26 Jan 2015, the vaccine was at 0.8 degree Celsius for 36 minutes and on 31 Jan 2015 the vaccine was at 0.6 degree Celsius for 35 minutes. No adverse events were reported following the maladministration.